Naomi Hammond

About A/Prof Naomi Hammond

Program Head

  • Associate Professor, Faculty of Medicine, UNSW Sydney
  • RN,
  • BN,
  • MN (Crit. Care),
  • MPH (with Merit),
  • PhD

Associate Professor Naomi Hammond is the Critical Care Program Head at The George Institute for Global Health. She also works part-time as the Intensive Care Clinical Research Manager at Royal North Shore Hospital, Sydney, Australia. Naomi holds several other appointments including NHMRC Emerging Leader Fellow; Conjoint Associate Professor at the Faculty of Medicine, University of New South Wales; an Editorial Board Member for Australian Critical Care Journal; Chair of the Australian Critical Care Nurses Research Advisory Panel; and Senior Research Fellow with the Australian Sepsis Network.

Naomi is a clinical nurse researcher and has led a program of sepsis research through international collaborations including facilitating 4 clinical trials in COVID-19 in India.  She leads the Australian and New Zealand Intensive Care Society Point Prevalence program. She has also undertaken international point prevalence studies including a large epidemiological study of patients with sepsis in Indian ICUs. Called the SIPS (Sepsis in India Prevalence) study, it has provided vital insights into changing epidemiology with different sepsis definitions, bacteriology, and antimicrobial resistance patterns.

Naomi’s main research interests include fluid resuscitation, sepsis, fever management, knowledge translation and implementation research, health economics, and long-term outcomes post-critical illness. Naomi has experience supervising and mentoring medical trainees, nursing staff, PhD, Masters and medical students in both the clinical and academic environment.

Additional to Naomi’s academic portfolio, she also has extensive clinical trials operational management experience including finance, regulatory processes, personnel, project and program management in a clinical and NGO environment.

Continuous versus intermittent beta-lactam antibiotic infusions in critically ill patients: The UK cohort of the BLING III trial

Journal of the Intensive Care Society Date published:

Convalescent plasma in hospitalised patients with COVID -19

Internal Medicine Journal Date published:

Mortality trends for sepsis and septic shock among critically ill adults in Australia and New Zealand

Intensive Care Medicine Date published:

The prevalence and use of arterial catheters in adult intensive care units: An Australian and New Zealand point prevalence study

Australian Critical Care Date published:

Related Readings